Inhibikase Therapeutics Inc. (IKT)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
2. 38
+0.07
+3.0303%
After Hours
$
+0.04 +1.6807% 2. 42
305M Market Cap
- P/E Ratio
- Div Yield
523,234 Volume
-1.77 Eps
$ 2.31
Previous Close 
Want to track IKT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
IKT Earnings Reports FAQ
What is the earnings per share (EPS) for IKT?
The current EPS is -1.77.
What is the company's earnings growth rate?
Inhibikase Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Inhibikase Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Inhibikase Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for IKT at this time, as Inhibikase Therapeutics Inc has no recent EPS data to calculate it.
